116.66

0.83% -1.22

Biontech Se Adr (BNTX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Perché BNTX Giù? Forum Previsione Storia dei dividendi

Precedente Chiudi:

$117.88

Aprire:

$118.88

Volume 24 ore:

132.66K

Relative Volume:

0.18

Capitalizzazione di mercato:

$28.26B

Reddito:

$3.30B

Utile/perdita netta:

$-501.07M

Rapporto P/E:

-55.17

EPS:

-2.1146

Flusso di cassa netto:

$1.03B

1 W Prestazione:

-2.44%

1M Prestazione:

-0.29%

6M Prestazione:

+31.37%

1 anno Prestazione:

+26.06%

Intervallo 1D:

$116.52

$119.49

Intervallo di 1 settimana:

$115.66

$124.49

Portata 52W:

$76.53

$131.49

Biontech Se Adr Stock (BNTX) Company Profile

Nome

Biontech Se Adr

Settore

Healthcare (1174)

Industria

Biotechnology (677)

Telefono

Indirizzo

Dipendente

6,133

Cinguettio

@BioNTech_Group

Prossima data di guadagno

2024-11-04

Ultimi documenti SEC

BNTX's Discussions on Twitter

Confronta BNTX con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
BNTX Biontech Se Adr	116.64	28.26B	3.30B	-501.07M	1.03B	-2.1146
VRTX Vertex Pharmaceuticals Inc	480.92	123.34B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	694.26	76.09B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	647.81	39.34B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	249.97	32.49B	2.25B	-278.16M	-42.59M	-2.17

Biontech Se Adr Stock (BNTX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-01-10	Iniziato	Truist	Buy
2024-12-11	Iniziato	Wells Fargo	Overweight
2024-12-02	Reiterato	BMO Capital Markets	Outperform
2024-11-19	Iniziato	Berenberg	Buy
2024-11-19	Aggiornamento	Evercore ISI	In-line → Outperform
2024-11-08	Aggiornamento	Goldman	Neutral → Buy
2024-09-24	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2024-09-17	Aggiornamento	Jefferies	Hold → Buy
2024-09-16	Aggiornamento	JP Morgan	Underweight → Neutral
2024-08-07	Aggiornamento	Deutsche Bank	Hold → Buy
2024-08-02	Aggiornamento	HSBC Securities	Hold → Buy
2024-05-14	Iniziato	Evercore ISI	In-line
2024-02-23	Iniziato	BMO Capital Markets	Outperform
2024-01-05	Iniziato	Oppenheimer	Perform
2023-12-01	Downgrade	JP Morgan	Neutral → Underweight
2023-10-16	Downgrade	HSBC Securities	Buy → Hold
2023-07-14	Iniziato	HSBC Securities	Buy
2023-05-17	Aggiornamento	Redburn	Neutral → Buy
2022-12-15	Aggiornamento	BofA Securities	Neutral → Buy
2022-08-17	Iniziato	Cowen	Market Perform
2022-07-13	Aggiornamento	SVB Leerink	Mkt Perform → Outperform
2022-07-06	Ripresa	Canaccord Genuity	Buy
2022-02-01	Aggiornamento	Redburn	Sell → Neutral
2021-12-16	Iniziato	Morgan Stanley	Equal-Weight
2021-11-10	Aggiornamento	H.C. Wainwright	Neutral → Buy
2021-10-22	Iniziato	Deutsche Bank	Hold
2021-10-07	Iniziato	Jefferies	Hold
2021-08-11	Aggiornamento	Bryan Garnier	Neutral → Buy
2021-07-19	Ripresa	Wolfe Research	Outperform
2021-06-16	Downgrade	Redburn	Neutral → Sell
2021-05-18	Iniziato	Goldman	Neutral
2021-05-11	Downgrade	Bryan Garnier	Buy → Neutral
2020-12-01	Downgrade	BofA Securities	Buy → Neutral
2020-08-03	Ripresa	Berenberg	Buy
2020-07-21	Aggiornamento	BofA Securities	Neutral → Buy
2020-06-30	Downgrade	H.C. Wainwright	Buy → Neutral
2020-05-19	Aggiornamento	H.C. Wainwright	Neutral → Buy
2020-04-28	Downgrade	BofA/Merrill	Buy → Neutral
2020-03-18	Downgrade	JP Morgan	Overweight → Neutral
2020-03-09	Iniziato	H.C. Wainwright	Neutral
2020-01-24	Downgrade	SVB Leerink	Outperform → Mkt Perform
2020-01-22	Downgrade	UBS	Buy → Neutral
2019-11-05	Iniziato	Wolfe Research	Outperform
2019-11-04	Iniziato	Berenberg	Buy
2019-11-04	Iniziato	BofA/Merrill	Buy
2019-11-04	Iniziato	Canaccord Genuity	Buy
2019-11-04	Iniziato	JP Morgan	Overweight
2019-11-04	Iniziato	SVB Leerink	Outperform
2019-11-04	Iniziato	UBS	Buy